Monday, June 15, 9:00 – 10:30 pm
Auditorium Lulli

Chairs: Markus Moehler (Germany) – Dave Wang 

1. Early-onset gastroesophageal cancer – a distinct entity? – Irit Ben-Aharon (Israel) 
2. After neoadj therapy with (n)cCR, local endoscopic resections? – Pech Oliver 
3. Pro: First joice Chemo (instead of CROSS) in adenocarcinoma of esophagus. – Eduardo Terán
4. Contra: First joice CROSS (instead Chemo) in adenocarcinoma of esophagus. – Mike Gibson
5. De-escalation strategies in oesogastric adenocarcinomas: is the time right? – Christelle De la Fouchardière (France)
6. Young or old: Do we differentiate in intensity of multimodal care? TBD
7. MSI: how do we treat, w+w or operate? – Thierry André (France)
8. ASCO 2026: New important SOC-changing phase III trials? – Lucjan Wyrwicz
9. Multidisciplinary Tumor Board-Harmonizing other Local and Systemic Control in Gastric or Gastroesophageal Cancer. – Hanoch Kashtan
10. Decision making and translational research: Challenges and evidence in tumor conferences. – Tania Fleitas Kanonnikoff 
11. Sport program and Resilience: what helps in perioperative setting? – Katja Petrowski

Monday, June 15, 9:00 – 10:30 am
Auditorium Richelieu

Chairs: Walter W. Chan (USA) – C. Prakash Gyawali (USA)

1. Belch or no belch: what is the approach to belching disorders? – Santosh Sanagapalli (Australia)
2. When to suspect and confirm the diagnosis of rumination? – Akinari Sawada (Japan)
3. How do symptom-specific anxiety and hypervigilance intersect with esophageal conditions? – Livia Guadagnoli (USA)
4. What is the role of brain-gut behavioral therapy in treating esophageal symptoms? – Megan Riehl (USA)
5. How to leverage pharmacologic neuromodulation for esophageal symptoms. – José María Remes Troche​ (Mexico)
6. Are there roles for complementary therapies for treating esophageal symptoms? – Chien-Lin (Harry) Chen (Taiwan)

Panel Chat/Q&A

Monday, June 15, 11:00 am – 12:30 pm
Auditorium Richelieu

Chairs: Daniel Sifrim (UK) – 

1. How should non-cardiac chest pain be diagnosed? – Ronnie Fass (USA)
2. How is functional heartburn different from reflux-induced heartburn? – Frank Zerbib (France)
3. Should reflux hypersensitivity be managed as a DGBI, GERD, or both? – Edoardo Savarino (Italy)
4. Is globus a LPRD symptom or a primary DGBI? – Shobna Bhatia (India)
5. What test(s) should be performed to diagnose functional dysphagia? – Sabine Roman (France)
6. How does functional dyspepsia overlap with esophageal symptoms or disorders? – Braden Kuo (USA)

Panel Chat/Q&A

Monday June 15, 11:00 am – 12:30 pm
Auditorium Condé

Chairs: Mouen Khashab (USA), Philip Chiu (Hong Kong), Joo Ha Hwang (USA), Byung-Wook Kim (Korea)
Discussants: Helmut Messmann (Germany), Sung Kwan Shin (Korea)
 

   I. POEM and Third-Space Procedures

1. Does the side of mucosal entry affect POEM procedure outcomes? – Toshitaka Hoppo (USA)
2. What is the true incidence of reflux after POEM & how can that be reduced? – Jean-Michel Gonzalez (France)
3. Does it matter whether full-thickness or circular muscle-only myotomy is performed for POEM? – Philip Chiu (Hong Kong)
4. Do we know the long-term durability of POEM? – Tomoaki Matsumura (Japan)
5. Can we predict which patients will fail POEM? – Anthony Berger (France) 
6. Should we aim for same day discharge after POEM? – Micaela Esquivel (USA)​​
   
   
   II. Endoscopic Submucosal Dissection & Tumor Resection
    
7. How large is too large for ESD in 2026? – Byung-Wook Kim (Korea)
8. How deep is too deep for ESD in 2026? – Hiroyuki​ Aihara (USA)
9. Is endoscopic ultrasound helpful or required for optimal ESD? – Helmut Messmann (Germany)
10. Will artificial intelligence change the way we perform ESD? – Sung Kwan Shin (Korea)
11. What technological advances are needed for ESD to make the next leap forward? – Shai Friedland (USA)
12. What are the next steps for 3rd space endoscopy in the esophagus? – Anthony Kalloo (USA)

Monday, June 15, 2:00 – 3:30 pm
Auditorium Lulli

Chairs: Frank Zerbib (France) – Nikki Johnston (USA)

1. What does the San Diego Consensus change in clinic? – Thomas L. Carroll (USA)
2. Is GMA biomarker subtyping the key to understanding and treating GERD/LPR? – Mark Noar (USA)
3. Alginate, H2RA, PPI, neuromodulation, or lifestyle first—what’s your first script? – Jacqui Allen (New Zealand)
4. What is the current understanding of the role of reflux in promoting laryngopharngeal cancer? – Jérôme R. Lechien (Belgium)
5. Are PCABs effective for LPRD? – Carmelo Scarpignato (Italy) 
6. What is the status of pepsin inhibitors for LPR? – Nikki Johnston (USA)
7. Which surgical or endoscopic options work for extra-esophageal disease? Stefano Siboni (Italy)
8. Pediatrics: are kids just little adults when it comes to LPRD? – (TBA)

Motion: “This house supports the San Diego Consensus Statement as the governing guideline for LPRD.”

• FOR: Walter W. Chan (USA) – (defending the Consensus statements & pathways).
• AGAINST: Inna Husain (USA) – (challenging external validity, symptom-first pathways, and laryngology-specific nuances).

Case-Based Panel + Audience Interaction:

1. Professional singer with chronic throat clearing and normal EGD: “Treat or test first?”
   Panel: Martin Birchall (UK) – Inna Husain (USA) – Mark Noar (USA)
2. Chronic cough with normal acid exposure but high non-acid events: “Does therapy change?”
   Panel: Thomas L. Carroll (USA) – ​Jonathan Bock (USA) – Jacqui Allen (New Zealand)
3. Mucosal protection: formulations and their place in the management of GERD and LPR
   Panel: Carmelo Scarpignato (Italy) – Edoardo Savarino (Italy) – Serhat Bor (Turkey)
4. Refractory LPS after maximal PPI & alginate: “Is it time for surgery or is it not reflux?”
   Panel: Stefano Siboni (Italy) – Jonathan Gould (USA) – Jérôme R. Lechien (Belgium)

3 take-home messages aligned to consensus language: Frank Zerbib (France)

Monday, June 15, 2:00 – 03:30 pm
Auditorium Richelieu

Panel Chat/Q&A

Monday June 15, 2:00 – 3:30 pm
Auditorium Condé

Monday, June 15, 4:00 – 05:30 pm
Auditorium Richelieu

Panel Chat/Q&A

Monday June 15, 4:00 – 5:30 pm
Auditorium Condé

Tuesday June 16, 9:00 – 10:30 pm
Auditorium Lulli

Chairs: Carmelo Scarpignato (Malta) – C. Prakash Gyawali (USA)
 

I – Acid Suppression: Present and Future

1. Acid Suppression: Limitations of the Current Antisecretory Drugs. Why do PPIs fail in some patients, and what are the true boundaries of acid suppression? – Justin Wu (Hong Kong)
2. Potassium-competitive Acid Blockers (P-CABs): A Step Forward in Acid Suppression. Do they really represent a paradigm shift or just an incremental advance? – Carmelo Scarpignato (Malta)
3. P-CABs for GERD: When and How. Patient profiles, timing, and switching strategies. – Ronny Fass (USA)
4. Alginate-containing Formulations: Before, With, or After PPIs? Optimizing the synergy between mechanical and pharmacologic acid control. – Serhat Bor (Turkey)
   
   II – Mucosal Protection and Beyond 
5. Mucosal Protective Compounds for GERD: How Much Are They Effective? Evidence and clinical relevance of sucralfate, hyaluronic acid–chondroitin sulfate, and similar agents. – Daniel Sifrim (UK)
6. The Status of Pepsin Inhibitors for PPI-Refractory GERD and LPR. A promising approach or another dead end? – Nikki Johnston (USA)
   
   III – Motility & Neuromodulation
7. GI Prokinetics: Which Role in GERD? From metoclopramide to acotiamide—any real progress? José María Remes Troche (Mexico)
8. When Are Neuromodulators Indicated in GERD? Functional heartburn, reflux hypersensitivity, and esophageal perception. C. Prakash Gyawali (USA)
   
   IV – Eosinophilic Esophagitis (EoE)
9. PPIs or Steroids for EoE: Alone or in Combination? Balancing efficacy, safety, and long-term management. Nirmala Gonsalves (USA)
10. EoE: When to Start Biologic Therapy and How? Current position of anti–IL-13/IL-4 agents and future perspectives. Nicola De Bortoli (Italy)
    
    V – Motor Disorders & New Frontiers
11. Smooth Muscle Relaxants for Achalasia: Still a Bridge Treatment? Are pharmacologic options still relevant in the POEM era? Mark Fox (Switzerland)
12. Long-term Safety and Pharmacogenetics of Acid Suppression. Are we ready for tailored therapy and precision acid suppression? Walter W. Chan (USA)
13. Reflux Inhibitors: A Promise Unfulfilled or a Niche Therapy? TargeQng TLESRs: TranslaQonal Failures and Clinical Residues – Marcelo Vela (USA)

Tuesday June 16, 9:00 – 10:30 am
Auditorium Richelieu

Chairs: Arnulf Hölscher (Germany) – Giovanni De Manzoni (Italy) – Stefan Mönig (Switzerland) 

1. Which classification system we need 2026? Giovanni De Manzoni (Italy) 
2. Double Tract reconstruction after limited resection. Johannes Zacherl (Austria)
3. How long we can wait after neoadjuvant treatment for surgery and how long we should wait? Mickael Chevallay (Switzerland)
4. Which access is the best open, HYBRID or minimal invasive? Frank Benedix (Germany)
5. What is the safest anastomotic technique after esophagectomy? Paul Schneider (Switzerland)
6. How we can prevent and treat Enterothorax after Esophagectomy? Christian Gutschow (Switzerland)

Panel Chat/Q&A

Tuesday June 16, 9:00 – 10:30 am
Auditorium Condé

Tuesday, June 16, 11:00 am – 12:30 pm
Auditorium Richelieu

Chairs: Vincent Wentao Fang (China) – Peter Grimminger (Germany) – Guido Schumacher (Italy)​

1. Is there a place for surgery in proximal cancer? Ian Wong (Hong Kong) 
2. When we need McKeown, when Ivor-Lewis approach is sufficient? Shaun Preston (UK)
3. What is necessary extent of lymphadenectomy in thoracic esophageal cancer? Ines Gockel (Switzerland)
4. Technical aspects of cervical anastomosis after McKewon esophagectomy? Jari Räsänen (Finland)
5. What are the arguments for surgery in squamous cell carcinoma? Guillaume Piessen (France)
6. What are the pitfalls for salvage esophagectomy? Sheraz Markar (UK)

Panel Chat/Q&A

Tuesday June 16, 11:00 am – 12:30 pm
Auditorium Condé

Tuesday, June 16, 2:00 – 3:30 pm
Auditorium Lulli

Endoscopic Reflux Therapy

1. Is anti-reflux mucosectomy ready for prime-time? – Ping-Huei Tseng (Taiwan)
2. Who is the ideal patient for transoral incisionless fundoplication? – Medhat Fanous (USA)
3. Why do c-TIF instead of a standard fundoplication? – Reginald Bell (USA)
4. What is the long-term success & durability of TIF? – Kenneth Chang (USA)
5. How large a hernia is too large to address with c-TIF? – Marcia (Mimi) Canto (USA)
6. Can AI help us better predict which endoscopic therapy is most likely to be successful? – Lee Swanström (France)
    

Complications of Endoluminal Intervention

1. How to approach mucosal erosion from the Linx device? – Emanuele Asti (Italy)
2. What are the key complications to be aware of from TIF or cTIF? – TBD
3. How to approach a blown-out myotomy? – Daryl Ramai (USA)
4. What is the optimal way to address significant reflux after POEM? – Mouen Khashab (USA)
5. Is megaesophagus now endoscopically treatable? – Salih Samo

​
Keynote Talk: What will the frontiers of surgical endoscopy be in the next 20 years? – Philip Chiu (Hong Kong)

Tuesday June 16, 2:00 – 3:30 pm
Auditorium Richelieu

Chairs: John O. Clarke (USA) – Edoardo Savarino (Italy)

1. Do we really know what causes EoE? – Amanda Muir (USA)
2. What is the role for allergy testing for EoE patients? – Emily McGowan (USA)
3. How should one ideally pursue an EoE-elimination diet? – Calies Menard-Katcher (USA)
4. How to approach medical therapy for EoE: my algorithm? – Christoph Schlag (Switzerland)
5. What is the role for artificial intelligence in EoE? – Pierfrancesco Visaggi (Italy)
6. How will we treat EoE in 10 years? – Nirmala Gonsalves (USA)

Panel Chat/Q& A

Tuesday June 16, 2:00 – 3:30 pm
Auditorium Condé

1. Dynamic Esophageal Radiology
2. Benign stenosis: measurements for treatment
3. Dynamic Radiology in esophageal carcinoma
4. Dynamic Radiology of the PE segment: the perspective of surgery
5. Dynamic Radiology: the perspective of bariatric surgery
6. Dynamic Radiology: the gastroenterologic perspective             

Panel Chat/Q&A

Tuesday, June 16, 4:00 – 5:30 am
Auditorium Lulli

Chairs: Eric Van Cutsem – Anneli Elme – Mike Gibson

1. ESMO standards of care: equal to other countries in the world? – Radka L. Obermannová (Czech Republic) 
2. Biomarker in advanced esophageal cancers: what do we need to know. – Magali Svrcek (France) 
3. Eastern Perspectives on Esophageal Cancer – Exploring Regional Differences in Clinical Characteristics and Treatment Strategies, with a Focus on ESD. – Hwoon-Yong Jung (Korea)
4. Molecular response prediction in esophageal squamous cell carcinomas: results of the EORTC/SAKK POWER project. – Alexander Siebenhuener 
5. IO tailored personalized medicine included side effects, drug holidays and maintenance. – Ian Chau (UK) 
6. Oligometastatic disease: recommendations or studies ahead? – Şuayib Yalçın 
7. Gender medicine: already prime-time? – Anna Wagner 
8. ASCO 2026: important news and approvals ahead? TBD 
9. Dr. Gibson’s talk on oncology. – Mike Gibson 
10. Liquid biopsies and Artificial intelligence (AI) as a practical decision support tool for oncologists: ready for prime time? – Ajay Goel

Tuesday, June 16, 4:00 – 5:30 pm
Auditorium Richelieu

Chairs: Walter W. Chan (USA) – C. Prakash Gyawali (USA)

1. When do PPI fail and when should PCAB be considered in treating reflux symptoms? – Enrique Coss-Adame (Mexico)
2. How should reflux symptoms refractory to PPI be evaluated? – Justin Wu (Hong Kong, China)
3. What other primary or adjunctive non-surgical options are useful for reflux symptoms? – Mark Fox (Switzerland)
4. What are the causes of failed fundoplication? – TBD
5. How should symptomatic post-fundoplication patients be assessed? – Renato Salvador (Italy)
6. When should endoscopic anti-reflux interventions be considered? – Kenneth Chang (USA)

Panel Chat/Q&A

Tuesday June 16, 4:00 – 5:30 pm
Auditorium Condé

Panel Chat/Q&A

Wednesday, June 17, 9:00 – 10:30 am
Auditorium Lulli

Chairs: Joshua Sloan (USA) – Daniela Jodorkovsky (USA) – Ellen Stein (USA)

1. When to FLIP – up-front, at the end, any time, or never? – Anh Nguyen (USA)
2. Advantages of barium esophagram versus FLIP for EGJ outflow obstruction. – Kristle Lynch (USA)
3. Achalasia subtyping: FLIP + Barium versus HREM alone. – Alberto Barchi (Italy)
4. Achalasia treated, recurrent– how to evaluate? – Daniela Jodorkovsky (USA)
5. Achalasia treated, recurrent - recut or dilate? – Jordi Serra (Spain)
6. Treatment of spastic disorders in the esophagus (non-achalasia): pharmacologic versus endoscopic interventions – Joan Chen (USA)
7. Only time for one provocative maneuver today – how do you choose – MRS, Rapid drink or SLR?  – Daphne Ang (Singapore)
8. Treatment or observation for Ineffective Esophageal Motility, which is better? – Jorge Luis​ Espinoza-Rios (Peru)
9. Pre-operative testing for GERD: esophageal manometry AND imaging or is less more. – Albis Hani (Colombia)
10. Absent contractility and proven GERD: lifestyle modification and medical management or wrap? – Reena Chokshi (USA)
11. Should we care more or less about bolus clearance during HREM? – Yeong Yeh Lee (Malaysia)
12. An abnormal looking manometry that is NORMAL by Chicago 4.0 Explore or ignore. – Luis Raúl Valdovinos García (Mexico)

Wednesday, June 17, 9:00 – 10:30 am
Auditorium Richelieu

Chairs: Arnulf H. Hölscher (Germany) – Riccardo Rosati (Italy)

Wednesday, June 17, 9:00 – 10:30 am
Auditorium Condé

Wednesday, June 17, 11:00 am – 12:30 pm
Auditorium Lulli

Chairs: Minoa K. Jung (Switzerland) – (TBA) 

1. How does obesity impact esophageal physiology? – Eric Sheu (USA)
2. Should esophageal physiologic testing be routinely performed prior to bariatric intervention? – Brent Hiramoto (USA) 
3. How should dysphagia following bariatric surgery be evaluated? – Ayman AlMuhaidb (Saudi Arabia)
4. Can bariatric surgery cause achalasia and achalasia-like disorders? – Karthik Ravi (USA)
5. How do weight regain and associated interventions affect esophageal symptoms? – Ahmad Najdat Bazarbashi (Saudi Arabia)
6. What are the consequences of intragastric balloons on esophageal and gastrointestinal symptoms? – Allison Schulman (USA)
   
   Panel Chat/Q&A
    
7. What are the mechanisms underlying excessive reflux following bariatric surgery? – Minoa K. Jung (Switzerland)
8. How should reflux following bariatric surgery be managed? – Ralph Peterli (Switzerland)
9. What is the approach to a hiatal hernia following bariatric surgery? – Salvatore Tolone (Italy)
10. Do endoscopic gastric remodeling procedures cause esophageal symptoms? – (TBA)
11. What are the esophageal and gastrointestinal side effects of GLP-1 receptor agonist use? – Nayna Lodhia (USA)
12. What is the impact of obesity and weight loss interventions on the risk of Barrett’s esophagus and esophageal cancer? – Nitin Ahuja (USA)

Wednesday, June 17, 11:00 am – 12:30 pm
Auditorium Richelieu

Panel Chat/Q&A

Wednesday, June 17, 11:00 am – 12:30 pm
Auditorium Condé

Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Lulli

Chairs: Mark Fox (Switzerland) – Kerry Dunbar (USA)

1. How should the optimal reflux monitoring modality and protocol be selected for different reflux presentations? – Marcelo Vela (USA)
2. Can patients with AET <4% off PPI have actionable GERD? – Wei-Yi (Ray) Lei (Taiwan)
3. How should reflux-symptom association data on reflux monitoring tests be used for planning symptom management? – Riblosi
4. What is the optimal management for reflux hypersensitivity. – Neha Patel (USA)
5. The AET is 4-6% off PPI – now what? – Nicola De Bortoli (Italy)
6. Can total reflux episode count on impedance monitoring direct management? – Benjamin Rogers (USA)
   
   Panel Chat/Q&A
    
7. What methods are available for clinical measurement of esophageal mucosal integrity? – TBD
8. What are the roles of mucosal impedance metrics in evaluating typical and atypical reflux symptoms? – Adriana Lazarescu (Canada)
9. Are there roles for barium esophagram and high-resolution manometry in GERD evaluation? – Stefano Siboni (Italy)
10. How can FLIP be utilized for GERD diagnosis and management? – Abraham Khan (USA)
11. What is the diagnostic approach to suspected reflux-related airway diseases? – TBD
12. How can reflux management protect the lungs in pre- and post-transplant patients? – Wai-Kit Lo (USA)

Panel Chat/Q&A

Wednesday, June 17, 2:00 am – 3:30 pm
Auditorium Richelieu

Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Condé

Chairs: Manfred Lutz – Christelle De la Fouchardière (France) – Dave Wang  

S = Session | CS = Chair | DS = Discussant
MS = Motility course | CMS = Chair Motility course | PMS = Presenter Motility course | DMS = Discussant Motility course
 

(speakers will continue to be added as they are confirmed)

• Nitin Ahuja (University of Pennsylvania, USA) (GI) – S28
• Hiroyuki Aihara (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI) – S6
• Jacqui Allen (University of Auckland, New Zealand) (ENT) – S7 – DS7
• Aymen AlMuhaidb (King Faisal Specialist Hospital, Saudi Arabia) (GI) – S28
• Thierry André (Hospital Saint-Antoine, Paris, France) (Oncology) – S1
• Daphne Ang (Changi General Hospital, Singapore) (GI) – S25
• Emanuele Asti (University of Milan, Italy) (Surgery) – S19 – S27
• Chang Seok Bang (Hallym University College of Medicine, Korea) (GI)
• Alberto Barchi (IRCCS San Raffaele Scientific Institute, Italy) (GI) – S25
• Ahmad Najdat Bazarbashi (King Faisal Specialist Hospital, Saudi Arabia) (GI) – S28
• Reginald Bell (Past President, American Foregut Society) (Surgery) – S19
• Irit Ben-Aharon (Rambam Health Care Campus, Israel) (Oncology) – S1
• Frank Benedix (University Hospital Magdeburg, Germany) – S14
• Anthony Berger (France) – S6
• Felix Berlth (Universitätsklinik Tübingen, Germany) (Surgery) – S8
• Katharina Beyer (Universitätsklinikum Augsburg, Germany) (Surgery)
• Claire Beveridge (Cleveland Clinic, USA) – S12
• Shobna Bhatia (HBT Medical College Mumbai, India) (GI) – S5
• Martin Birchall (University College London, UK) (ENT) – DS7
• ​Jonathan Bock (Medical College of Wisconsin, USA) (ENT) – DS7
• Serhat Bor (Ege University, Turkey) (GI) – DS7
• Baruch Brenner (Rabin Medical Center, Israel) (Oncology) – S33
• Marcia (Mimi) Canto (Johns Hopkins University, USA) (GI) – S19 – S27 – CS29
• Thomas L. Carroll (Brigham and Women’s Hospital, Harvard Medical School, USA) (ENT) – S7 – DS7
• Walter W. Chan (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI) – DMC – CS2 – DS7 – CS23
• Kenneth Chang (Hoag Health, USA) (GI) – S19 – S23
• Deyali Chatterjee (Vanderbilt University, USA) (Pathology) – S30
• Ian Chau (The Royal Marsden – NHS Foundation Trust, UK) (Oncology) – S22
• Chien-Lin (Harry) Chen (Hualien Tzu Chi Hospital, Tzu Chi University, Taiwan) (GI) – S2
• Joan Chen (University of Michigan, USA) (GI) – S25
• Judy Chen (University of Washington, USA) (Surgery) – S15
• Philip Chiu (Chinese University of Hong Kong, Hong Kong SAR) (Surgery) – CS6 – S6 – DS19
• Yu Kyung Cho (The Catholic University of Korea, Korea) (GI)
• Reena Chokshi (Baylor College of Medicine, USA) (GI) – S25
• Seung-hun Chon (University Hospital of Cologne, Germany) (Surgery)
• Daniel Cisternas (Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Chili) (GI)
• John O. Clarke (Stanford University School of Medicine, USA) (GI) – S12 – CS20
• Don C. Codipilly (Mayo Clinic, USA) (GI) – S29
• Yaniv Cozacov (Horizon Health, USA) (Surgery) – S32
• Enrique Coss-Adame (Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico) (GI) – S23
• Eric Van Cutsem – CS22
• Tanuja Damani (NYU, USA) (Surgery) – S11
• Nicola de Bortoli (University of Pisa, Italy) (GI) – S31
• Hiroyuki Daiko (National Cancer Center Hospital in Tokyo, Japan)
• Christelle De la Fouchardière (Institut PAOLI-CALMETTES, Marseille, France) (Oncology) – S1 – CS33
• Giovanni De Manzoni (University of Verona, Italy) – CS14 – S14
• Massimiliano Di Pietro (University of Cambridge, UK) (GI) – S29
• Bastian Dislich (University of Bern, Switzerland) (Pathology) – S30
• Kerry Dunbar (University of Texas Southwestern, USA) (GI) – S29 – CS31
• Anneli Elme – CS22 – S33
• Moustafa Elshafai (Krankenhaus Nordwest) (Surgery)
• Jorge Luis Espinoza Rios (Cayetano Heredia Medical School, Peru) (GI) – S25
• Micaela Esquivel (Stanford University School of Medicine, USA) (Surgery) – S6
• Vincent Wentao Fang (Shanghai East Hospital, China) (Surgery) – CS17
• Medhat Fanous (Aspirus Iron River Hospitals and Clinics, USA) (Surgery) – CS32 – S32 – S19
• Ronnie Fass (MetroHealth Medical Center, Case Western Reserve University, USA) (GI) – S5
• Nielsen Fernandez-Becker (Stanford University, USA) (GI)
• Mark Fox (University Hospital Zurich and Klinik Arlesheim, Switzerland) (GI) – S23 – CS31
• Shai Friedland (Stanford University School of Medicine, USA) (GI) – S6
• Sravanya Gavini (The University of Texas Southwestern, USA) (GI) – MC – PMC
• Gaurav Ghosh (Cornell, USA) (GI)
• Simone Giacopuzzi (University of Verona, Italy) (Surgery) – S8
• Mike Gibson – S1 – CS22 – S22
• Suzanne Gisbertz (Amsterdam UMC, Holland) (Surgery)
• Gaurav Ghosh (USA) – MC – PMC
• Ines Gockel (University Hospital and Clarahospital of Basel, Switzerland) (Visceral Surgery) – S17 – S27 – S33
• Ajay Goel – S22
• Nirmala Gonsalves (Northwestern University, USA) (GI) – CS12 – S20
• Jean-Michel Gonzalez (France) – S6
• Jonathan Gould (Medical College of Wisconsin, USA) (Surgery) – DS7
• Matthew Greenhawt (University of Colorado Childrens, USA) – S12
• Robert Giuli (OESO, France) (Surgery)
• Peter Grimminger (University Medical Center Mainz, Germany) (Surgery) – S8 – CS11 – CS17
• Livia Guadagnoli (Northwestern Feinberg School of Medicine, USA) (Psychology) – S2
• Maha Guindi (Cedars Sinai, USA) (Pathology)
• Christian Gutschow (Universitätsspital Zürich, Switzerland) (Surgery) – S14
• C. Prakash Gyawali (Washington University School of Medicine, USA) (GI) – DMC – CS2 – CS23
• Suntrea Hammer (UT Southwestern, USA) (Pathology) – S30
• Albis Hani (Pontificia Universidad Javeriana, Colombia) (GI) – S25
• Joo Ha Hwang (Stanford, USA) (GI)
• Brent Hiramoto (University of Southern California, USA) (GI) – S28
• Daikō Hiroyki (National Cancer Center Hospital, Japan) Surgery
• Arnulf Hölscher (Elisabeth-Krankenhaus-Essen GmbH, Germany) (Surgery) – CS14
• Toshitaka Hoppo (Rutgers Robert Wood Johnson Medical School, USA) (Surgery) – S6
• Jennifer Horsley-Silva (Mayo Clinic, USA) (GI) – DS12 – S12
• Inna Husain (Indiana University School of Medicine, USA) (ENT) – DS7
• Joo Ha Hwang (Stanford University School of Medicine, USA) (GI) – CS6
• Prasad Iyer (Mayo Clinic, USA) (GI) – S27 – CS29
• Dhanpat Jain (Yale University School of Medicine, New Haven, USA) – CS30
• Yan Jiang (Stanford University School of Medicine, USA) (GI) – MC – PMC
• Daniela Jodorkovsky (Mount Sinai School of Medicine, USA) (GI) – CS25 – S25
• Nikki Johnston (Medical College of Wisconsin, USA) (ENT) – CS7
• Kee Wook Jung (University of Ulsan, Korea) (GI)
• Da Hyun Jung (Yonsei University College of Medicine, Korea) (GI)
• Hwoon-Yong Jung (University of Uslan College of Medicine, Korea) (GI) – S22
• Minoa K. Jung (Hôpitaux Universitaires de Genève, Switzerland) (Surgery) – CS28 – S28
• Allon Kahn (Mayo Clinic, USA) (GI) – S15 – S29
• Anthony Kalloo (Johns Hopkins University, USA) (GI) – S6
• Afrin Kamal (Stanford University School of Medicine, USA) (GI) – CS15
• Tania Fleitas Kanonnikoff – S1
• Hanoch Kashtan – S1
• Paul Menard Katcher (USA) – MC – PMC
• Priya Kathpalia (University of California San Francisco, USA) (GI) – MC – PMC
• Ronan Kelly (Baylor Scott White, USA) (Oncology)
• Courtney Kemp (Twin Cities Heartburn Center, USA) (Surgery) – S15
• Abraham Khan (New York University Langone School of Medicine, USA) (GI) – S31
• Mouen Khashab (Johns Hopkins University, USA) (GI) – CS6 – S19
• Do Hoon Kim (University of Ulsan, Korea) (GI)
• Dagmar P. Kollmann (University of Vienna, Austria) (Surgery) – CS32 – S32
• Byung-Wook Kim (Catholic University of Korea, Korea) (GI) – S6
• Do Hoon Kim (University of Ulsan, Korea) (GI)
• Vani Konda (Baylor Scott and White Health, USA) (GI)
• Yusef Kudsi (Harvard University, USA) (Surgery) – CS11
• Braden Kuo (Columbia University Vagelos College of Physicians and Surgeons, USA) (GI) – S5
• Jasmina Kuvendjiska (University Medical Center Freiburg, Germany) 
• Rupert Langer (Kepler University Hospital and Johannes Kepler University, Linz, Austria) – CS30
• Adriana Lazarescu (University of Alberta, Canada) (GI) – S31
• Jérôme R. Lechien (Université de Mons, Belgium) (ENT) – S7 – DS7
• Ju Yup Lee (Keimyung University, Korea) (GI)
• Sang Kil Lee (Yonsei University, Korea) (GI)
• Yeong Yeh Lee (Universiti Sains Malaysia, Malaysia) (GI) – S25
• Wei-Yi (Ray) Lei​ (Hualien Tzu Chi Hospital, Taiwan) – S31
• Mikhail Lisovsky (Dartmouth University, USA) (Pathology) – S30
• Wai-Kit Lo (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI) – S31
• Nayna Lodhia (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI) – S28
• Sara Lonardi (Veneto Institute of Oncology IOV, Italy) (Oncology) – S33
• Manfred Lutz – CS33
• Kristle Lynch (University of Pennsylvania, USA) (GI) – S25
• Pavan Mallur (Harvard University, USA) (ENT Surgery)
• Stella Mantziari (CHU de Lille, FR) GI – S32
• Celia Marginean (Baylor College of Medicine, USA) (Pathology)  – S30
• Sheraz Markar (University of Oxford, UK) (Surgery) – S15 – S17
• Tomoaki Matsumura (Chiba University Hospital, Japan) (GI) – S6
• Emily McGowan (University of Virginia, USA) (Allergy) – DS12 – S20
• Calies Menard-Katcher (Childrens Colorado USA) (GI) – S20
• Paul Menard-Katcher (University of Colorado USA) (GI)
• Helmut Messmann (Germany) – S6
• Jean-Philippe Metges (CHU de Brest, France) (Oncology) – S33
• Markus Moehler (Johannes-Gutenberg University, Germany) (Oncology) – S1 – S33
• Andrés Francisco Navarrete Molina (Clínica Alemana, Chile) (Surgery) – CS8 – S8
• Stefan Mönig (Hôpitaux Universitaires de Genève, Switzerland) (Surgery) – CS14
• Jacob Moremen (University of Mississippi Medical Center, USA) (Surgery) – S15
• Mayssan Muftah (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI) – S12
• Amanda Muir (Children’s Hospital of Philadelphia, University of Pennsylvania, USA) (GI) – S20
• Beat Müller (University Digestive Healthcare Center Basel, Switzerland) (Surgery) – S11 – S33
• Michael Murray (USA) – S32
• Ilke Nalbantoglu (Yale University, USA) (Pathology) – S30
• Anh Nguyen (Baylor University Medical Center of Dallas, USA) (GI) – MC – S25 
• Mark Noar (Endometriosis and Neurogastroenterology Research Institute, USA) (GI) – S7 – DS7
• Radka L. Obermannová (Masaryk Memorial Cancer Institute, Brno, Czech Republic) (Oncology) – S22
• Jung-Hwan Oh (The Catholic University of Korea, Korea) (GI)
• Oliver Old (Gloucestershire Hospitals NHS Foundation Trust, UK) (Surgery) – S29
• Pech Oliver – S1
• Darshan Parekh (Mumbai Institute of Gastroenterology, India) (GI)
• Moo In Park (Kosin University, Korea) (GI)
• Walter Park (Stanford University School of Medicine, USA) (GI)
• Neha Patel (UT Southwestern Medical Center, USA) – S31
• Silvana Peretta (Université de Strasbourg, France) (Surgery) – S11
• Ralph Peterli (St. Clara Hospital and University Hospital, Switzerland) – S28
• Katja Petrowski – S1
• Guillaume Piessen (CHU de Lille, France) (Surgery) – S17
• Peter Pokieser (Medical University of Vienna, Austria) (Radiology)
• Shaun Preston (Royal Surrey NHS, UK) (Surgery) – S17
• Alberto Puccini (IRCCS Humanitas Research Hospital, Italy) (Oncology) – S33
• Daryl Ramai (University of Utah, USA) (GI) – S19 – S27
• Jari Räsänen (Helsinki University Hospital, Finland) – S17 
• Karthik Ravi (Mayo Clinic, USA) (GI) – S28
• William Ravich (Yale University School of Medicine, USA) (GI) – S12
• Matthew Read (St. Vincent's Hospital, Melbourne, Australia) – CS8
• José María Remes Troche (Universidad Veracruzana, Mexico) (GI) – S2 – DMC
• Florence Renaud (INSERM/University of Paris, France) (Pathology) – S30
• Sun Young Rha (Yonsei University College of Medicine, Korea) (Oncology)
• Riblosi – S31
• Allyson Richardson (USA) – MC – PMC
• Megan Riehl (University of Michigan, USA) (Psychology) – S2
• Benjamin Rogers (University of Louisville, USA) (GI) – PMC – S31
• Sabine Roman (CHU Lyon, France) (GI) – S5
• Riccardo Rosati (IRCCS San Raffaele Scientific Institute and San Raffaele Vita-Salute University, Italy) (Surgery)
• Rubens Sallum (University of Sao Paolo, Brazil) (Surgery) – CS11 – S11
• Renato Salvador (University of Padua, Italy) (Surgery) – DMC – S23
• Salih Samo – S19
• Santosh Sanagapali (St. Vincent’s Hospital, University of New South Wales, Australia) (GI) – S2
• Netu Sarkaria (UT Southwestern, USA) (Surgery) – S11
• Bryan Sauer (University of Virginia, USA) (GI)
• Edoardo Savarino (University of Padua, Italy) (GI) – S5 – DS7 – CS20
• Akinari Sawada (Osaka Metropolitan University, Japan) (GI) – PMC – S2
• Carmelo Scarpignato (United Campus of Malta, Malta) (Pharmacology) – S7 – DS7
• Christoph Schlag (University Hospital Zurich, Switzerland) (GI) – S20
• Paul Schneider (Center for Surgery Zurich, Switzerland)  – S14
• Tilmann Schlick (Intuitive Surgical Deutschland, Germany)
• Sebastian Schoppmann (Medical University of Vienna, Austria) (Surgery) – S15
• Allison Schulman (University of Michigan, USA) (GI) – S28
• Guido Schumacher (South Tyrol Health Service, Brixen, Italy) – CS17
• Jordi Serra (University Hospital Vall d'Hebrón, Spain) (GI) – S25
• Eric Shah (University of Michigan, USA) (GI)
• Ealaf Shemmeri (Brigham and Women’s Hospital, USA) – S32
• Eric Sheu (Brigham and Women’s Hospital, Harvard Medical School, USA) (Surgery) – S28
• Eun Ji Shin (Johns Hopkins University, USA) (GI) – S27
• Sung Kwan Shin (Yonsei University College of Medicine, Korea) (GI) – DS6 – S6
• Stefano Siboni (IRCCS Policlinico San Donato, University of Milan, Italy) (Surgery) – DS7 – S31
• Alexander Siebenhuener – S22
• Daniel Sifrim (Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK) (GI) – CS5
• Aleksandar Simic (Belgrade) (Surgery)
• Joshua Sloan (University of Minnesota, USA) (GI) – S12 – CS25
• Michael Smith (Mount Sinai School of Medicine, USA) (GI) – S29
• Diana Snyder (Mayo Clinic, USA) (GI) – MC – PMC
• Renato Soares (Hospital Santa Cruz, Curtiba, Brazil) (Surgery) – S32
• Irene Sonu (Stanford University School of Medicine, USA) (GI) – PMC – MC
• Marco Sozzi (IRCCS Policlinico San Donato, University of Milan, Italy) (Surgery) – MC – PMC
• Magali Svrcek (France) (Pathology) – S22
• Ellen Stein (Rutgers University, USA) (GI) – DMC – S12 – CS25
• Alex Strauss (University of Pennsylvania, USA) – S12
• Cathy Streutker (Unity Health, Canada) (Pathology) – S30
• Lee Swanström (Institutes des Hôpitaux Universitaires, University of Strasbourg, France) (Surgery) – S19
• Flavio Takeda (University Sao Paolo) (Surgery)
• Roger Tatum (University of Washington, USA) (GI) – CS15 – DMC
• Eduardo Terán – S1
• Salvatore Tolone (University of Campania Luigi Vanvitelli, Italy) (Surgery) – S28
• David Tougeron (CHU de Poitiers, France) (Oncology) – S33
• Monika Tripathi (Unity Health, Canada) (Pathology) – S30
• Ping-Huei Tseng (National Taiwan University, Taiwan) (GI) – S15 – S19
• Luis Raúl Valdovinos García (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico) (GI) – S25
• Tim Underwood (University of Southhampton, UK) – S14
• Kenneth Vega (Prisma Health, USA) (GI) – S27
• Marcelo Vela (Mayo Clinic, USA) (GI) – S31
• Felipe Victor – S11
• Pierfrancesco Visaggi (University of Pisa, Italy) (GI) – CS12 – S20
• Anna Wagner – S22
• Dave Wang – S1 – CS33
• Russell E. White (Tenwek Hospital, Kenya) Surgery – S32
• Ian Wong (Queen Mary Hospital, Hong Kong) Surgery – S17
• Marc Wong (Chinese University of Hong Kong, Hong Kong SAR) (GI) – MC – PMC
• Phillip Woodworth (Institute of Esophageal and Reflux Surgery Colorado, USA) – S32
• Andrew Wright (University of Washington) Surgery
• Justin Wu (Chinese University of Hong Kong, Hong Kong SAR) (GI) – S23
• Lucjan Wyrwicz – S1
• Şuayib Yalçın – S22
• Hyo-Joon Yang (Sungkyunkwan University School of Medicine, Korea) (GI)
• Robert Yates (University of Washington) Surgery
• Aziz Zaanan (European George Pompidou Hospital, University of Paris Cite, France) (Oncology)
• Johannes Zacherl (Medical University of Vienna, Austria) – S14
• Frank Zerbib (Bordeaux University, France) (GI) – S5 – CS7 – DS7
• Adam Zeyara (Lund University, Sweden) (Surgery) – S32
• Xuchen Zhang (Yale University, USA) (Pathology) – S30
• Lei Zhao (Brigham and Women’s hospital, Boston, USA (Pathology) – S30
• Margaret Zhou (Stanford, USA) (GI) – S27